Work

Sodium‐glucose co‐transporter type‐2 inhibitors: pharmacology and peri‐operative considerations

Year: 2018
Type: review
Abstract: Sodium-glucose co-transporter 2 (SGLT2) inhibitors are an emerging class of oral hypoglycaemic agents with therapeutic benefits beyond better glycaemic control. A major concern of the sodium-glucose co-transporter 2 inhibitors is their propensity to cause euglycaemic ketoacidosis in the peri-operative period and the potential for this critical diagnosis to be delayed or missed entirely. This review attempts to collate the case reports of sodium-glucose co-transporter 2 inhibitor ketoacidosis associated with surgery to highlight and put a perspective on this peri-operative issue. Preventive strategies and the management of the ketoacidosis are discussed.
Source: Anaesthesia
Language: English
Field: Medicine
Open Access status: bronze
OpenAlex ID: W2790875054
FWCI: 1.026
Cites: 60
Cited by: 99
Related to: 10